1
|
Zsiros J, Maibach R, Shafford E, Brugieres
L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A,
Laithier V, et al: Successful treatment of childhood high-risk
hepatoblastoma with dose-intensive multiagent chemotherapy and
surgery: Final results of the SIOPEL-3HR study. J Clin Oncol.
28:2584–2590. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang YT, Feng LH, Zhong XD, Wang LZ and
Chang J: Single-agent cisplatin treatment of children with
high-risk hepatoblastoma. J Pediatr Hematol Oncol. 36:271–275.
2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yu Y, Zhao X, Zhang Y, Kang Y, Wang J and
Liu Y: Antitumor activity of YM155, a selective survivin
suppressant, in combination with cisplatin in hepatoblastoma. Oncol
Rep. 34:407–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jimenez A, Santos A, Alonso G and Vazquez
D: Inhibitors of protein synthesis in eukarytic cells. Comparative
effects of some amaryllidaceae alkaloids. Biochim Biophys Acta.
425:342–348. 1976. View Article : Google Scholar : PubMed/NCBI
|
5
|
Toriizuka Y, Kinoshita E, Kogure N,
Kitajima M, Ishiyama A, Otoguro K, Yamada H, Omura S and Takayama
H: New lycorine-type alkaloid from Lycoris traubii and
evaluation of antitrypanosomal and antimalarial activities of
lycorine derivatives. Bioorg Med Chem. 16:10182–10189. 2008.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Shen JW, Ruan Y, Ren W, Ma BJ, Wang XL and
Zheng CF: Lycorine: A potential broad-spectrum agent against crop
pathogenic fungi. J Microbiol Biotechnol. 24:354–358. 2014.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Guo Y, Wang Y, Cao L, Wang P, Qing J,
Zheng Q, Shang L, Yin Z and Sun Y: A conserved inhibitory mechanism
of a lycorine derivative against enterovirus and hepatitis C virus.
Antimicrob Agents Chemother. 60:913–924. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lamoral-Theys D, Andolfi A, Van
Goietsenoven G, Cimmino A, Le Calvé B, Wauthoz N, Mégalizzi V, Gras
T, Bruyère C, Dubois J, et al: Lycorine, the main phenanthridine
Amaryllidaceae alkaloid, exhibits significant antitumor activity in
cancer cells that display resistance to proapoptotic stimuli: An
investigation of structure-activity relationship and mechanistic
insight. J Med Chem. 52:6244–6256. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zeng H, Fu R, Yan L and Huang J: Lycorine
induces apoptosis of A549 cells via AMPK-mammalian target of
rapamycin (mTOR)-S6K signaling pathway. Med Sci Monit.
23:2035–2041. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang C, Wang Q, Li X, Jin Z, Xu P, Xu N,
Xu A, Xu Y, Zheng S, Zheng J, et al: Lycorine induces apoptosis of
bladder cancer T24 cells by inhibiting phospho-Akt and activating
the intrinsic apoptotic cascade. Biochem Biophys Res Commun.
483:197–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cao Z, Yu D, Fu S, Zhang G, Pan Y, Bao M,
Tu J, Shang B, Guo P, Yang P, et al: Lycorine hydrochloride
selectively inhibits human ovarian cancer cell proliferation and
tumor neovascularization with very low toxicity. Toxicol Lett.
218:174–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. Febs J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sinha P, Hütter G, Köttgen E, Dietel M,
Schadendorf D and Lage H: Increased expression of epidermal fatty
acid binding protein, cofilin, and 14-3-3-sigma (stratifin)
detected by two-dimensional gel electrophoresis, mass spectrometry
and microsequencing of drug-resistant human adenocarcinoma of the
pancreas. Electrophoresis. 20:2952–2960. 1999. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gourlay CW and Ayscough KR: The actin
cytoskeleton: A key regulator of apoptosis and ageing? Nat Rev Mol
Cell Biol. 6:583–589. 2005. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Gross SR: Actin binding proteins: Their
ups and downs in metastatic life. Cell Adh Migr. 7:199–213. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ding W, Tan H, Zhao C, Li X, Li Z, Jiang
C, Zhang Y and Wang L: MiR-145 suppresses cell proliferation and
motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumour
Biol. 37:6255–6260. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Genda T, Sakamoto M, Ichida T, Asakura H,
Kojiro M, Narumiya S and Hirohashi S: Cell motility mediated by rho
and Rho-associated protein kinase plays a critical role in
intrahepatic metastasis of human hepatocellular carcinoma.
Hepatology. 30:1027–1036. 1999. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang J, Xu J and Xing G: Lycorine inhibits
the growth and metastasis of breast cancer through the blockage of
STAT3 signaling pathway. Acta Biochim Biophys Sin. 49:771–779.
2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Roy M, Liang L, Xiao X, Peng Y, Luo Y,
Zhou W, Zhang J, Qiu L, Zhang S, Liu F, et al: Lycorine
downregulates HMGB1 to inhibit autophagy and enhances bortezomib
activity in multiple myeloma. Theranostics. 6:2209–2224. 2016.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Aden DP, Fogel A, Plotkin S, Damjanov I
and Knowles BB: Controlled synthesis of HBsAg in a differentiated
human liver carcinoma-derived cell line. Nature. 282:615–616. 1979.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu Y, Bi T, Shen G, Li Z, Wu G, Wang Z,
Qian L and Gao Q: Lupeol induces apoptosis and inhibits invasion in
gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9
signaling pathway. Cytotechnology. 68:123–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li L, Dai HJ, Ye M, Wang SL, Xiao XJ,
Zheng J, Chen HY, Luo YH and Liu J: Lycorine induces cell-cycle
arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer
Cell Int. 12:492012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Li Y, Liu J, Tang LJ, Shi YW, Ren W and Hu
WX: Apoptosis induced by lycorine in KM3 cells is associated with
the G0/G1 cell cycle arrest. Oncol Rep. 17:377–384. 2007.PubMed/NCBI
|
25
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Benson CS, Babu SD, Radhakrishna S,
Selvamurugan N and Sankar Ravi B: Expression of matrix
metalloproteinases in human breast cancer tissues. Dis Markers.
34:395–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Komiya Y, Kurabe N, Katagiri K, Ogawa M,
Sugiyama A, Kawasaki Y and Tashiro F: A novel binding factor of
14-3-3beta functions as a transcriptional repressor and promotes
anchorage-independent growth, tumorigenicity, and metastasis. J
Biol Chem. 283:18753–18764. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Tang Y, Lv P, Sun Z, Han L and Zhou W:
14-3-3β promotes migration and invasion of human hepatocellular
carcinoma cells by modulating expression of MMP2 and MMP9 through
PI3K/Akt/NF-kappaB pathway. PLoS One. 11:e01460702016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Mendes O, Kim HT and Stoica G: Expression
of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat
model. Clin Exp Metastasis. 22:237–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Schram K, Ganguly R, No EK, Fang X, Thong
FS and Sweeney G: Regulation of MT1-MMP and MMP-2 by leptin in
cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal
reorganization and leads to enhanced cell migration. Endocrinology.
152:2037–2047. 2011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Liu X, Chen D and Liu G: Overexpression of
RhoA promotes the proliferation and migration of cervical cancer
cells. Biosci Biotechnol Biochem. 78:1895–1901. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J,
Kim YK, Kang J, Park CG, Han JW and Lee HY: The Rho/ROCK pathway
for lysophosphatidic acid-induced proteolytic enzyme expression and
ovarian cancer cell invasion. Oncogene. 31:4279–4289. 2012.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Ishaq M, Lin BR, Bosche M, Zheng X, Yang
J, Huang D, Lempicki RA, Aguilera-Gutierrez A and Natarajan V: LIM
kinase 1-dependent cofilin 1 pathway and actin dynamics mediate
nuclear retinoid receptor function in T lymphocytes. BMC Mol Biol.
12:412011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Flamini MI, Fu XD, Sanchez AM, Giretti MS,
Garibaldi S, Goglia L, Pisaneschi S, Tosi V, Genazzani AR and
Simoncini T: Effects of raloxifene on breast cancer cell migration
and invasion through the actin cytoskeleton. J Cell Mol Med.
13:2396–2407. 2009. View Article : Google Scholar : PubMed/NCBI
|
36
|
Freitas VM, Rangel M, Bisson LF, Jaeger RG
and Machado-Santelli GM: The geodiamolide H, derived from Brazilian
sponge Geodia corticostylifera, regulates actin
cytoskeleton, migration and invasion of breast cancer cells
cultured in three-dimensional environment. J Cell Physiol.
216:583–594. 2008. View Article : Google Scholar : PubMed/NCBI
|
37
|
Keshamouni VG, Michailidis G, Grasso CS,
Anthwal S, Strahler JR, Walker A, Arenberg DA, Reddy RC, Akulapalli
S, Thannickal VJ, et al: Differential protein expression profiling
by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing
epithelial-mesenchymal transition reveals a migratory/invasive
phenotype. J Proteome Res. 5:1143–1154. 2006. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wang W, Goswami S, Lapidus K, Wells AL,
Wyckoff JB, Sahai E, Singer RH, Segall JE and Condeelis JS:
Identification and testing of a gene expression signature of
invasive carcinoma cells within primary mammary tumors. Cancer Res.
64:8585–8594. 2004. View Article : Google Scholar : PubMed/NCBI
|
39
|
Yap CT, Simpson TI, Pratt T, Price DJ and
Maciver SK: The motility of glioblastoma tumour cells is modulated
by intracellular cofilin expression in a concentration-dependent
manner. Cell Motil Cytoskeleton. 60:153–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Salvarezza SB, Deborde S, Schreiner R,
Campagne F, Kessels MM, Qualmann B, Caceres A, Kreitzer G and
Rodriguez-Boulan E: LIM kinase 1 and cofilin regulate actin
filament population required for dynamin-dependent apical carrier
fission from the trans-Golgi network. Mol Biol Cell.
20:438–451. 2009. View Article : Google Scholar : PubMed/NCBI
|
41
|
Kaji N, Muramoto A and Mizuno K: LIM
kinase-mediated cofilin phosphorylation during mitosis is required
for precise spindle positioning. J Biol Chem. 283:4983–4992. 2008.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Martin San A, Lee MY, Williams HC, Mizuno
K, Lassègue B and Griendling KK: Dual regulation of cofilin
activity by LIM kinase and Slingshot-1L phosphatase controls
platelet-derived growth factor-induced migration of human aortic
smooth muscle cells. Circ Res. 102:432–438. 2008. View Article : Google Scholar : PubMed/NCBI
|
43
|
Okumura N, Ueno M, Koizumi N, Sakamoto Y,
Hirata K, Hamuro J and Kinoshita S: Enhancement on primate corneal
endothelial cell survival in vitro by a ROCK inhibitor. Invest
Ophthalmol Vis Sci. 50:3680–3687. 2009. View Article : Google Scholar : PubMed/NCBI
|
44
|
Nakamura K, Yoshimura A, Kaneko T, Sato K
and Hara Y: ROCK inhibitor Y-27632 maintains the proliferation of
confluent human mesenchymal stem cells. J Periodontal Res.
49:363–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
45
|
Del Debbio CB, Santos MF, Yan CY, Ahmad I
and Hamassaki DE: Rho GTPases control ciliary epithelium cells
proliferation and progenitor profile induction in vivo. Invest
Ophthalmol Vis Sci. 55:2631–2641. 2014. View Article : Google Scholar : PubMed/NCBI
|